The latest market report published by Credence Research, Inc. “Global Listeria monocytogenes Infections Treatment Market was valued at USD 3,624.9 Mn in 2015, and is expected to reach USD 5,056.3 Mn by 2022, expanding at a CAGR of 4.74% from 2016 to 2022.
The purpose of the report is to illustrate the state of the market of Listeria Monocytogenes Infections Treatment, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2016, and also, to build a forecast for the growth of the industry in the medium term until 2022.
Market Insights:
Listeria monocytogenes, is an important pathogen in pregnant patients, neonates, elderly individuals, and immunocompromised individuals, although an uncommon cause of illness in the general population. Listeria monocytogenes is a bacterial pathogen capable of causing severe infections in humans, often with fatal outcomes. According to USFDA, published studies suggest that 1- 8% of humans may be intestinal carriers of Listeria. According to Unites States Department of Agriculture (USDA), Listeria causes about 280 cases of illness in newborns in a typical year, resulting in 60 deaths and stillbirths. Infants can be infected before birth, and this infection can cause serious disability in newborns. About 35 infants are disabled as a result of infection from Listeria each year. The key factors assisting the growth of Listeria monocytogenes infections treatment market are rise in prevalence of foodborne diseases, stringent laws and policies issued by FDA, rising demand for healthy and microbial-free food, and high public awareness related to foodborne diseases in developed countries.
Leading Players:
1 Pfizer Inc.
2 Novartis AG
3 Merck & Co.
4 Astra Zeneca plc
5 Johnson & Johnson Limited
6 Abbott Laboratories
7 Eli Lilly and Company
8 Sanofi SA
9 Medimmune
10 Baxter International, Inc.
Browse here for full report with Toc: https://www.credenceresearch.com/report/listeria-monocytogenes-infections-treatment-market
Why was the report written?
This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Listeria Monocytogenes Infections Treatment buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.
Browse here for full report with Toc: https://www.credenceresearch.com/report/listeria-monocytogenes-infections-treatment-market
What is the current market landscape and what is changing?
Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.
The report on the market of Listeria Monocytogenes Infections Treatment contains:
Analysis and forecast of Listeria Monocytogenes Infections Treatment market dynamics;
Analysis of domestic production, market shares of the main market players;
Analysis of exports and imports;
Analysis of factors, leading the development of the Listeria Monocytogenes Infections Treatment market;
Assessment and forecast of Listeria Monocytogenes Infections Treatment market development;
Financial and business profiles of the leading companies in the Listeria Monocytogenes Infections Treatment industry.
Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/57831
Scope
– Up to date working Listeria Monocytogenes Infections Treatment data by major regions in the world, the forecast of planned capacity additions by 2026
– The annual breakdown of capital expenditure spending on proposed Listeria Monocytogenes Infections Treatment for the period 2018 to 2026
– Planned Listeria Monocytogenes Infections Treatment additions and capital expenditure spending by key countries and companies across the world
– Planned capital expenditure spending on new Listeria Monocytogenes Infections Treatment projects by region, key countries, and companies
– Details of major planned Listeria Monocytogenes Infections Treatment projects in the world up to 2026
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/CANADA): +1-800-361-8290